Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ENTA
Tag: NASDAQ:ENTA
ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA) Files An 8-K Results of Operations and...
ME Staff 8-k
-
February 6, 2019
0
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) price target set to $100.00 by Oppenheimer
ME Staff
-
November 27, 2018
0
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) had its Buy rating reiterated by JMP...
ME Staff
-
July 31, 2018
0
Analyst Activity – Roth Capital Initiates Coverage On NASDAQ:ENTA – Enanta...
ME Staff
-
June 6, 2018
0
Analyst Activity – Royal Bank of Canada Reiterates Hold on ENTA...
ME Staff
-
April 4, 2018
0
Analyst Activity – Royal Bank of Canada Raises Its Price Target...
ME Staff
-
February 8, 2018
0
ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
September 13, 2017
0
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) reported earnings of ($0.44) per share beating...
ME Staff
-
August 7, 2017
0
ENANTA PHARMACEUTICALS, INC. (NASDAQ:ENTA) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 7, 2017
0
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Maviret Authorized For Sale In EU
Andy Parker
-
August 2, 2017
0
1
2
Page 1 of 2
